ArticleEpilepsy & behavior : E&B2021
COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.
Article in Epilepsy & behavior : E&B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.
- Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023Pooled it
- Should patients with epilepsy be vaccinated against coronavirus disease 2019? A systematic review and meta-analysis.Epilepsy & behavior : E&B · 2022Pooled it
- Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.The journal of headache and pain · 2022Pooled it
- Prospective study of safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine in tuberous sclerosis complex children on sirolimus.Human vaccines & immunotherapeutics · 2025Article
- Central nervous system manifestations following vaccination against COVID-19.Brain, behavior, & immunity - health · 2024Review
- Article
- COVID-19 vaccinations for patients with epilepsy in Guizhou Province, China: A cross-sectional study.Heliyon · 2024Article
- Article
- New-Onset Focal to Bilateral Tonic-Clonic Seizure Following COVID-19 Vaccination.Case reports in neurological medicine · 2024Article
- SARS-CoV-2 vaccination in paediatric patients with epilepsy: experience of a tertiary center in Colombia.Revista de neurologia · 2023Article
- Experiences from COVID-19 vaccination in patients with epilepsy.Epilepsia open · 2023Article
- Safety and Tolerability of COVID-19 Vaccine in Children With Epilepsy: A Prospective, Multicenter Study.Pediatric neurology · 2023Article
- Effects of COVID-19 Infection and Vaccines on Patients with Epilepsy: Real-Life Experiences.Noro psikiyatri arsivi · 2023Article
- The effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: A clinical observation in China.Human vaccines & immunotherapeutics · 2022Observational
- Seizures following COVID-19 vaccination in Mexico: A nationwide observational study.Epilepsia · 2022Observational
- Observational retrospective analysis of vaccination against SARS-CoV-2 and seizures: VACCI-COVID registry.Epilepsy & behavior : E&B · 2022Observational
- COVID-19 vaccination for patients with benign childhood epilepsy with centrotemporal spikes.Epilepsy & behavior : E&B · 2022Article
- Impact of the COVID-19 pandemic on people with epilepsy: findings from the US arm of the COV-E study.Epilepsia open · 2022Article
- COVID-19 vaccine-related frequently asked questions (FAQs) by people with epilepsy and carers in Iran; educational video is included.Epilepsy & behavior : E&B · 2022Article
- Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDue to the high demand for information regarding COVID-19 vaccination in people with epilepsy (PWE), we assessed the symptoms and seizure control of PWE following their COVID-19 vaccination.
methodsAll adult patients who were treated at our center were asked to report on their vaccination status and, if vaccinated, about their experiences following their first COVID-19 vaccination with regard to adverse effects and seizure control.
resultsFifty-four PWE have already received their first vaccination against COVID-19 (27 female, 20% seizure free, 96<% on antiseizure medication) and were included in the study. Two-thirds tolerated the vaccines generally either very well or well. Thirty-three percent reported general vaccination adverse effects. The most frequently reported general adverse effects were, in descending order, headache, fatigue and fever, and shivering. With regard to epilepsy-related adverse effects, one patient reported increased seizure frequency one day after the first COVID-19 vaccination was administered, and one reported the occurrence of a new seizure type. None of the patients reported a status epilepticus or aggravation of preexisting adverse effects.
conclusionsOur data suggest that vaccination against COVID-19 appears to be well tolerated in PWE, supporting the recommendation of vaccination to PWE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.